Q32 Bio(DE:DB0)
€8.34+-0.03 (+1.21%)
DE:DB0
Q32 Bio financials statements
€8.34
At close:+-0.03 (+1.21%)
Q32 Bio (DB0) Ratios
2 Followers
Q32 Bio Ratios
DE:DB0's free cash flow for Q3 2026 was $-4.47M. For the 2026 fiscal year, DE:DB0's free cash flow was decreased by $-52.00K and operating cash flow was $-4.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.85 | 4.97 | 2.04 | 0.81 | 11.14 |
| Quick Ratio | 4.85 | 4.97 | 2.04 | 0.78 | 11.14 |
| Cash Ratio | 4.26 | 4.74 | 1.82 | 0.76 | 6.29 |
| Solvency Ratio | 1.53 | -0.55 | -0.23 | -0.22 | -2.05 |
| Operating Cash Flow Ratio | -2.96 | -4.11 | -1.32 | -0.19 | -6.37 |
| Short-Term Operating Cash Flow Coverage | -4.84 | -21.86 | -21.27 | -0.34 | -446.14 |
| Net Current Asset Value | $ 35.29M | $ -4.78M | $ -201.26M | $ -145.63M | $ 149.84M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.20 | 1.08 | 0.72 | 0.11 |
| Debt-to-Equity Ratio | 0.37 | 3.33 | -0.28 | -0.34 | 0.14 |
| Debt-to-Capital Ratio | 0.27 | 0.77 | -0.38 | -0.52 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.63 | -0.31 | -0.04 | 0.00 |
| Financial Leverage Ratio | 1.47 | 16.27 | -0.26 | -0.47 | 1.25 |
| Debt Service Coverage Ratio | 3.90 | -13.34 | -54.75 | -1.20 | -350.49 |
| Interest Coverage Ratio | 15.37 | -220.34 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.25 | 0.30 | 1.25 | 0.52 | 0.00 |
| Interest Debt Per Share | 1.34 | 1.57 | 15.80 | 14.03 | 7.79 |
| Net Debt to EBITDA | -1.05 | 1.30 | -0.53 | -0.02 | 0.98 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 0.00% | 100.00% | 100.00% | 71.91% |
| EBIT Margin | 57.54% | 0.00% | 725.53% | -589.76% | -281.90% |
| EBITDA Margin | 58.27% | 0.00% | 718.03% | -584.20% | -253.80% |
| Operating Profit Margin | 31.45% | 0.00% | 725.53% | -589.76% | -282.44% |
| Pretax Profit Margin | 55.49% | 0.00% | 803.26% | -642.72% | -281.90% |
| Net Profit Margin | 55.49% | 0.00% | 808.04% | -643.65% | -281.90% |
| Continuous Operations Profit Margin | 55.49% | 0.00% | 808.04% | -643.65% | -281.90% |
| Net Income Per EBT | 100.00% | 100.04% | 100.60% | 100.15% | 100.00% |
| EBT Per EBIT | 176.43% | 72.18% | 110.71% | 108.98% | 99.81% |
| Return on Assets (ROA) | 48.27% | -51.70% | -114.21% | -69.30% | -45.23% |
| Return on Equity (ROE) | 70.98% | -841.11% | 29.38% | 32.75% | -56.45% |
| Return on Capital Employed (ROCE) | 33.52% | -87.13% | -146.46% | -1003.45% | -49.33% |
| Return on Invested Capital (ROIC) | 29.47% | -83.07% | -140.42% | -106.64% | -49.27% |
| Return on Tangible Assets | 48.27% | -51.70% | -114.21% | -69.30% | -45.23% |
| Earnings Yield | 73.02% | -113.76% | -152.63% | -59.19% | -47.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | -8.81 | 6.25 | 0.00 |
| Payables Turnover | 0.00 | 0.16 | 0.00 | 0.00 | 4.03 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.84 | 0.00 | -0.82 | 0.73 | 1.90 |
| Asset Turnover | 0.87 | 0.00 | -0.14 | 0.11 | 0.16 |
| Working Capital Turnover Ratio | 0.98 | 0.00 | -3.70 | 0.08 | 0.18 |
| Cash Conversion Cycle | 0.00 | -2240.22 | -41.43 | 58.39 | -90.49 |
| Days of Sales Outstanding | 0.00 | 0.00 | -41.43 | 58.39 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 2240.22 | 0.00 | 0.00 | 90.49 |
| Operating Cycle | 0.00 | 0.00 | -41.43 | 58.39 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.73 | -5.55 | -5.80 | -3.44 | -35.73 |
| Free Cash Flow Per Share | -2.73 | -5.56 | -5.80 | -4.22 | -36.51 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -902.87 | -3735.40 | -4.41 | -45.81 |
| Capital Expenditure Coverage Ratio | 0.00 | -902.87 | -3735.40 | -4.41 | -45.81 |
| Operating Cash Flow Coverage Ratio | -2.19 | -3.58 | -0.37 | -0.24 | -4.59 |
| Operating Cash Flow to Sales Ratio | -0.62 | 0.00 | 2.81 | -1.65 | -3.23 |
| Free Cash Flow Yield | -82.14% | -161.56% | -53.06% | -18.59% | -55.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.37 | -0.67 | -0.66 | -1.69 | -2.10 |
| Price-to-Sales (P/S) Ratio | 0.76 | 0.00 | -5.29 | 10.87 | 5.92 |
| Price-to-Book (P/B) Ratio | 0.97 | 7.39 | -0.19 | -0.55 | 1.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.22 | -0.62 | -1.88 | -5.38 | -1.79 |
| Price-to-Operating Cash Flow Ratio | -1.22 | -0.62 | -1.89 | -6.60 | -1.83 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.01 | -0.03 | -0.17 | 0.03 |
| Enterprise Value Multiple | 0.25 | 0.38 | -1.27 | -1.88 | -1.35 |
| Enterprise Value | 7.88M | -17.10M | 60.43M | 73.16M | 116.78M |
| EV to EBITDA | 0.25 | 0.38 | -1.27 | -1.88 | -1.35 |
| EV to Sales | 0.15 | 0.00 | -9.09 | 11.00 | 3.44 |
| EV to Free Cash Flow | -0.24 | 0.25 | -3.23 | -5.44 | -1.04 |
| EV to Operating Cash Flow | -0.24 | 0.25 | -3.24 | -6.68 | -1.06 |
| Tangible Book Value Per Share | 3.42 | 0.47 | -56.83 | -40.99 | 55.24 |
| Shareholders’ Equity Per Share | 3.42 | 0.47 | -56.83 | -40.99 | 55.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.01 | -0.00 | 0.00 |
| Revenue Per Share | 4.37 | 0.00 | -2.07 | 2.09 | 11.06 |
| Net Income Per Share | 2.42 | -3.91 | -16.70 | -13.42 | -31.18 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 1.00 | 1.00 |
| Interest Burden | 0.96 | 1.04 | 1.11 | 1.09 | 1.00 |
| Research & Development to Revenue | 0.36 | 0.00 | -4.77 | 5.38 | 2.74 |
| SG&A to Revenue | 0.33 | 0.00 | -1.48 | 1.51 | 0.00 |
| Stock-Based Compensation to Revenue | 0.10 | 0.00 | -0.21 | 0.19 | 0.00 |
| Income Quality | -1.12 | 1.42 | 0.35 | 0.26 | 1.15 |
Currency in USD
